drugset / Trial / NCT02120365
Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence
Phase 1/2
Completed
22 enrolled
Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collabUniversity of Connecticut · collabYale University · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to determine whether perampanel alters the response to alcohol for heavy drinkers. It is hypothesized that perampanel will reduce the rewarding and reinforcing properties of alcohol in the laboratory setting.
Timeline
- Start
- 2019-06-01
- Primary completion
- 2022-02-15
- Completion
- 2022-02-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Perampanel | Small molecule | 6 mg | — |
| Subject | Perampanel | Small molecule | 10 mg | — |